About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 869505, 8 pages
http://dx.doi.org/10.1155/2012/869505
Review Article

Characteristics of Plasmacytoid Dendritic Cell and CD4+ T Cell in HIV Elite Controllers

1CNRS UMR 8147 and Hôpital Necker, Université Paris Descartes, 149-161 rue de Sèvres, 75015 Paris, France
2CNRS UMR 8601, Université Paris Descartes, 45 rue des Saint-Pères, 75006 Paris, France
3Unité d'Immunologie Humaine, Centre Medical Necker Pasteur, Institut Pasteur, 28 Rue du Docteur Roux, 75015 Paris, France

Received 21 August 2012; Revised 22 October 2012; Accepted 23 October 2012

Academic Editor: Vicki L. Traina-Dorge

Copyright © 2012 Jean-Philippe Herbeuval et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Schmidt, B. M. Ashlock, H. Foster, S. H. Fujimura, and J. A. Levy, “HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration,” Virology, vol. 343, no. 2, pp. 256–266, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. F. P. Siegal, N. Kadowaki, M. Shodell et al., “The nature of the principal Type 1 interferon-producing cells in human blood,” Science, vol. 284, no. 5421, pp. 1835–1837, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Grouard, M. C. Rissoan, L. Filgueira, I. Durand, J. Banchereau, and Y. J. Liu, “The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand,” Journal of Experimental Medicine, vol. 185, no. 6, pp. 1101–1111, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Barchet, M. Cella, and M. Colonna, “Plasmacytoid dendritic cells—virus experts of innate immunity,” Seminars in Immunology, vol. 17, no. 4, pp. 253–261, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Colonna, G. Trinchieri, and Y. J. Liu, “Plasmacytoid dendritic cells in immunity,” Nature Immunology, vol. 5, no. 12, pp. 1219–1226, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. J. Liu, “IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors,” Annual Review of Immunology, vol. 23, pp. 275–306, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Cella, D. Jarrossay, F. Faccheth et al., “Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon,” Nature Medicine, vol. 5, no. 8, pp. 919–923, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Kadowaki, S. Antonenko, J. Y. N. Lau, and Y. J. Liu, “Natural interferon α/β-producing cells link innate and adaptive immunity,” Journal of Experimental Medicine, vol. 192, no. 2, pp. 219–226, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. S. J. Gibson, J. M. Lindh, T. R. Riter et al., “Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod,” Cellular Immunology, vol. 218, no. 1-2, pp. 74–86, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Krug, A. R. French, W. Barchet et al., “TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function,” Immunity, vol. 21, no. 1, pp. 107–119, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Jego, A. K. Palucka, J. P. Blanck, C. Chalouni, V. Pascual, and J. Banchereau, “Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6,” Immunity, vol. 19, no. 2, pp. 225–234, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. G. X. Yang, Z. X. Lian, K. Kikuchi et al., “Plasmacytoid dendritic cells of different origins have distinct characteristics and function: studies of lymphoid progenitors versus myeloid progenitors,” The Journal of Immunology, vol. 175, no. 11, pp. 7281–7287, 2005. View at Scopus
  13. D. Jarrossay, G. Napolitani, M. Colonna, F. Sallusto, and A. Lanzavecchia, “Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells,” European Journal of Immunology, vol. 31, no. 11, pp. 3388–3393, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Kadowaki and Y. J. Liu, “Natural type I interferon-producing cells as a link between innate and adaptive immunity,” Human Immunology, vol. 63, no. 12, pp. 1126–1132, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Hemmi, T. Kaisho, O. Takeuchi et al., “Small-antiviral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway,” Nature Immunology, vol. 3, no. 2, pp. 196–200, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. S. S. Diebold, T. Kaisho, H. Hemmi, S. Akira, and C. Reis E Sousa, “Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA,” Science, vol. 303, no. 5663, pp. 1529–1531, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Heil, H. Hemmi, H. Hochrein et al., “Species-specific recognition of single-stranded RNA via till-like receptor 7 and 8,” Science, vol. 303, no. 5663, pp. 1526–1529, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. Lund, L. Alexopoulou, A. Sato et al., “Recognition of single-stranded RNA viruses by Toll-like receptor 7,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 15, pp. 5598–5603, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Hemmi, O. Takeuchi, T. Kawai et al., “A Toll-like receptor recognizes bacterial DNA,” Nature, vol. 408, no. 6813, pp. 740–745, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Lund, A. Sato, S. Akira, R. Medzhitov, and A. Iwasaki, “Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells,” Journal of Experimental Medicine, vol. 198, no. 3, pp. 513–520, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. O. Duramad, K. L. Fearon, B. Chang et al., “Inhibitors of TLR-9 act on multiple cell subsets in mouse and man in vitro and prevent death in vivo from systemic inflammation,” The Journal of Immunology, vol. 174, no. 9, pp. 5193–5200, 2005. View at Scopus
  22. C. Guiducci, G. Ott, J. H. Chan et al., “Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation,” Journal of Experimental Medicine, vol. 203, no. 8, pp. 1999–2008, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Honda, Y. Ohba, H. Yanai et al., “Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction,” Nature, vol. 434, no. 7036, pp. 1035–1040, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Honda, H. Yanai, H. Negishi et al., “IRF-7 is the master regulator of type-I interferon-dependent immune responses,” Nature, vol. 434, no. 7034, pp. 772–777, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Uematsu, S. Sato, M. Yamamoto et al., “Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction,” Journal of Experimental Medicine, vol. 201, no. 6, pp. 915–923, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Hoshino, T. Sugiyama, M. Matsumoto et al., “IκB kinase-α is critical for interferon-α production induced by Toll-like receptors 7 and 9,” Nature, vol. 440, no. 7086, pp. 949–953, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Guiducci, C. Ghirelli, M. A. Marloie-Provost et al., “PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation,” Journal of Experimental Medicine, vol. 205, no. 2, pp. 315–322, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Dzionek, Y. Inagaki, K. Okawa et al., “Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions,” Human Immunology, vol. 63, no. 12, pp. 1133–1148, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Dzionek, Y. Sohma, J. Nagafune et al., “BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon α/β induction,” Journal of Experimental Medicine, vol. 194, no. 12, pp. 1823–1834, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Tordjman, Y. Lepelletier, V. Lemarchandel et al., “A neuronal receptor, neuropilin-I, is essential for the initiation of the primary immune response,” Nature Immunology, vol. 3, no. 5, pp. 477–482, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Salio, M. Cella, W. Vermi et al., “Plasmacytoid dendritic cells prime IFN-γ-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions,” European The Journal of Immunology, vol. 33, no. 4, pp. 1052–1062, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. F. O. Nestle, C. Conrad, A. Tun-Kyi et al., “Plasmacytoid predendritic cells initiate psoriasis through interferon-α production,” Journal of Experimental Medicine, vol. 202, no. 1, pp. 135–143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Bangert, J. Friedl, G. Stary, G. Stingl, and T. Kopp, “Immunopathologic features of allergic contact dermatitis in humans: participation of plasmacytoid dendritic cells in the pathogenesis of the disease?” Journal of Investigative Dermatology, vol. 121, no. 6, pp. 1409–1418, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Colonna, “Toll-like receptors and IFN-α: partners in autoimmunity,” Journal of Clinical Investigation, vol. 116, no. 9, pp. 2319–2322, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Marshak-Rothstein, “Toll-like receptors in systemic autoimmune disease,” Nature Reviews Immunology, vol. 6, no. 11, pp. 823–835, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. V. Soumelis, L. Scott, F. Gheyas et al., “Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients,” Blood, vol. 98, no. 4, pp. 906–912, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. I. Kamga, S. Kahi, L. Develioglu et al., “Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection,” Journal of Infectious Diseases, vol. 192, no. 2, pp. 303–310, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Müller-Trutwin and A. Hosmalin, “Role for plasmacytoid dendritic cells in anti-HIV innate immunity,” Immunology and Cell Biology, vol. 83, no. 5, pp. 578–585, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Barblu, K. Machmach, C. Gras, et al., “Plasmacytoid dendritic cells (pDCs) from HIV controllers produce interferon-a and differentiate into functional killer pDCs under HIV activation,” Of Infectious Diseases, vol. 206, no. 5, pp. 790–801, 2012.
  40. K. Machmach, M. Leal, C. Gras et al., “Plasmacytoid dendritic cells reduce HIV production in elite controllers,” Journal of Virology, vol. 86, no. 8, pp. 4245–4252, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Fitzgerald-Bocarsly and E. S. Jacobs, “Plasmacytoid dendritic cells in HIV infection: striking a delicate balance,” Journal of Leukocyte Biology, vol. 87, no. 4, pp. 609–620, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Benlahrech and S. Patterson, “HIV-1 infection and induction of interferon alpha in plasmacytoid dendritic cells,” Current Opinion in HIV and AIDS, vol. 6, no. 5, pp. 373–378, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. K. N. Brown, V. Wijewardana, X. Liu, and S. M. Barratt-Boyes, “Rapid influx and death of plasmacytoid dendritic cells in lymph nodes mediate depletion in acute simian immunodeficiency virus infection,” PLoS Pathogens, vol. 5, no. 5, Article ID e1000413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Fong, M. Mengozzi, N. W. Abbey, B. G. Herndier, and E. G. Engleman, “Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation,” Journal of Virology, vol. 76, no. 21, pp. 11033–11041, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Donaghy, B. Gazzard, F. Gotch, and S. Patterson, “Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1,” Blood, vol. 101, no. 11, pp. 4505–4511, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Otero, G. Nunnari, D. Leto et al., “Peripheral blood dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART,” AIDS Research and Human Retroviruses, vol. 19, no. 12, pp. 1097–1103, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Hansjee, G. R. Kaufmann, C. Strub, R. Weber, M. Battegay, and P. Erb, “Persistent apoptosis in HIV-1-infected individuals receiving potent antiretroviral therapy is associated with poor recovery of CD4+ T lymphocytes,” Journal of Acquired Immune Deficiency Syndromes, vol. 36, no. 2, pp. 671–677, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Lichtner, C. Marañón, P. O. Vidalain et al., “HIV type 1-infected dendritic cells induce apoptotic death in infected and uninfected primary CD4+ T lymphocytes,” AIDS Research and Human Retroviruses, vol. 20, no. 2, pp. 175–182, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Stary, I. Klein, S. Kohlhofer et al., “Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients,” Blood, vol. 114, no. 18, pp. 3854–3863, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Lehmann, M. Lafferty, A. Garzino-Demo et al., “Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients,” PloS ONE, vol. 5, no. 6, Article ID e11110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. J. F. Fonteneau, M. Larsson, A. S. Beignon et al., “Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells,” Journal of Virology, vol. 78, no. 10, pp. 5223–5232, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. J. P. Herbeuval, J. Nilsson, A. Boasso et al., “Differential expression of IFN-α and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 18, pp. 7000–7005, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. A. S. Beignon, K. McKenna, M. Skoberne et al., “Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions,” Journal of Clinical Investigation, vol. 115, no. 11, pp. 3265–3275, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Chaperot, A. Blum, O. Manches et al., “Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells,” The Journal of Immunology, vol. 176, no. 1, pp. 248–255, 2006. View at Scopus
  55. A. W. Hardy, D. R. Graham, G. M. Shearer, and J. P. Herbeuval, “HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-α,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 44, pp. 17453–17458, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. E. Khatissian, M. G. Tovey, M. C. Cumont et al., “The relationship between the interferon α response and viral burden in primary SIV infection,” AIDS Research and Human Retroviruses, vol. 12, no. 13, pp. 1273–1278, 1996. View at Scopus
  57. B. Reizis, A. Bunin, H. S. Ghosh, K. L. Lewis, and V. Sisirak, “Plasmacytoid dendritic cells: recent progress and open questions,” Annual Review of Immunology, vol. 29, pp. 163–183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. B. Malleret, B. Manéglier, I. Karlsson et al., “Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression,” Blood, vol. 112, no. 12, pp. 4598–4608, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. S. M. Barratt-Boyes, V. Wijewardana, and K. N. Brown, “In acute pathogenic SIV infection plasmacytoid dendritic cells are depleted from blood and lymph nodes despite mobilization,” Journal of Medical Primatology, vol. 39, no. 4, pp. 235–242, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Biancotto, J. C. Grivel, S. J. Iglehart et al., “Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1,” Blood, vol. 109, no. 10, pp. 4272–4279, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. C. Cellerai, A. Harari, H. Stauss et al., “Early and prolonged antiretroviral therapy is associated with an HIV-1-specific T-cell profile comparable to that of long-term non-progressors,” PLoS ONE, vol. 6, no. 4, Article ID e18164, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. J. N. Mandl, A. P. Barry, T. H. Vanderford et al., “Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections,” Nature Medicine, vol. 14, no. 10, pp. 1077–1087, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. O. M. Diop, M. J. Y. Ploquin, L. Mortara et al., “Plasmacytoid dendritic cell dynamics and alpha interferon production during simian immunodeficiency virus infection with a nonpathogenic outcome,” Journal of Virology, vol. 82, no. 11, pp. 5145–5152, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. B. Jacquelin, V. Mayau, B. Targat et al., “Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response,” Journal of Clinical Investigation, vol. 119, no. 12, pp. 3544–3555, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. S. E. Bosinger, Q. Li, S. N. Gordon et al., “Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys,” Journal of Clinical Investigation, vol. 119, no. 12, pp. 3556–3572, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. V. Sivaraman, L. Zhang, and L. Su, “Type I interferon contributes to CD4+ T cell depletion induced by infection with HIV-1 in the human thymus,” Journal of Virology, vol. 85, no. 17, pp. 9243–9246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. D. C. Douek, L. J. Picker, and R. A. Koup, “T cell dynamics in HIV-1 infection,” Annual Review of Immunology, vol. 21, pp. 265–304, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Okoye, M. Meier-Schellersheim, J. M. Brenchley et al., “Progressive CD4+ central-memory T cell decline results in CD4+ effector-memory insufficiency and overt disease in chronic SIV infection,” Journal of Experimental Medicine, vol. 204, no. 9, pp. 2171–2185, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. J. van Grevenynghe, F. A. Procopio, Z. He et al., “Transcription factor FOXO3a controls the persistence of memory CD4+ T cells during HIV infection,” Nature Medicine, vol. 14, no. 3, pp. 266–274, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. J. M. McCune, “The dynamics of CD4+ T-cell depletion in HIV disease,” Nature, vol. 410, no. 6831, pp. 974–979, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. R. M. Troyer, J. McNevin, Y. Liu et al., “Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response,” PLoS Pathogens, vol. 5, no. 4, Article ID e1000365, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. L. Harrison, H. Castro, P. Cane et al., “The effect of transmitted HIV-1 drug resistance on pre-therapy viral load,” AIDS, vol. 24, no. 12, pp. 1917–1922, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. S. J. Potter, C. Lacabaratz, O. Lambotte et al., “Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study,” Journal of Virology, vol. 81, no. 24, pp. 13904–13915, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Kryworuchko, V. Pasquier, and J. Thèze, “Human immunodeficiency virus-1 envelope glycoproteins and anti-CD4 antibodies inhibit interleukin-2-induced Jak/STAT signalling in human CD4+ T lymphocytes,” Clinical and Experimental Immunology, vol. 131, no. 3, pp. 422–427, 2003. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Kryworuchko, V. Pasquier, H. Keller et al., “Defective interleukin-2-dependent STAT5 signalling in CD8 T lymphocytes from HIV-positive patients: restoration by antiretroviral therapy,” AIDS, vol. 18, no. 3, pp. 421–426, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. D. David, L. Bani, J. L. Moreau et al., “Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 19, pp. 11348–11353, 1998. View at Publisher · View at Google Scholar · View at Scopus
  77. D. David, L. Bani, J. L. Moreau, et al., “Dysregulation of interleukin-2 receptor β and interleukin-2 receptor γ expression during HIV infection,” European Cytokine Network, vol. 9, no. 3, pp. 97–101, 1998. View at Scopus
  78. M. Paiardini, B. Cervasi, H. Albrecht et al., “Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals,” The Journal of Immunology, vol. 174, no. 5, pp. 2900–2909, 2005. View at Scopus
  79. R. M. Dunham, B. Cervasi, J. M. Brenchley et al., “CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection,” The Journal of Immunology, vol. 180, no. 8, pp. 5582–5592, 2008. View at Scopus
  80. A. Chahroudi and G. Silvestri, “Interleukin-7 in HIV pathogenesis and therapy,” European Cytokine Network, vol. 21, no. 3, pp. 202–207, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Zeng, A. J. Smith, S. W. Wietgrefe et al., “Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections,” Journal of Clinical Investigation, vol. 121, no. 3, pp. 998–1008, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. I. Sereti, R. M. Dunham, J. Spritzler et al., “IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection,” Blood, vol. 113, no. 25, pp. 6304–6314, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. Y. Levy, C. Lacabaratz, L. Weiss et al., “Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment,” Journal of Clinical Investigation, vol. 119, no. 4, pp. 997–1007, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. B. Vingert, S. Perez-Patrigeon, P. Jeannin et al., “HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity,” PLoS Pathogens, vol. 6, no. 2, Article ID e1000780, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. J. M. Brenchley, T. W. Schacker, L. E. Ruff et al., “CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract,” Journal of Experimental Medicine, vol. 200, no. 6, pp. 749–759, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. J. J. Mattapallil, D. C. Douek, B. Hill, Y. Nishimura, M. Martin, and M. Roederer, “Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection,” Nature, vol. 434, no. 7037, pp. 1093–1097, 2005. View at Publisher · View at Google Scholar · View at Scopus
  87. P. W. Hunt, J. Brenchley, E. Sinclair et al., “Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy,” Journal of Infectious Diseases, vol. 197, no. 1, pp. 126–133, 2008. View at Publisher · View at Google Scholar · View at Scopus